Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market definition
2.2. Market segmentation
3. Catheter Market Insights
3.1. Catheter – Industry snapshot
3.1.1. Leading Companies
3.1.2. Key Companies to Watch
3.2. Catheter - Ecosystem analysis
3.2.1. Disease overview
3.2.2. Commercial Landscape
3.3. Catheter Market Dynamics
3.3.1. Catheter – Market Forces
3.3.1.1. Catheter Market Driver Analysis
3.3.1.2. Catheter Market Restraint/Challenges analysis
3.3.1.3. Catheter Market Opportunity Analysis
3.3.2. Industry analysis - Porter's five forces
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Catheter Market PEST Analysis, 2017
3.3.4. Catheter Market Value Chain Analysis
3.3.5. Catheter Industry Trends
3.3.6. Competitive Ranking Analysis
4. Catheter Market Size and Forecast, 2017-2025 by Product Types
4.1. Key Findings
4.2. Cardiovascular Catheters
4.2.1. PTCA Balloon Catheters
4.2.2. IVUS Catheters
4.2.3. PTA Balloon Catheters
4.2.4. Electrophysiology catheters
4.2.5. Others
4.3. Urological Catheters
4.3.1. Foley Catheters
4.3.2. Hemodialysis Catheters
4.3.3. Peritoneal Catheters
4.3.4. Intermittent Catheters
4.3.5. External Catheters
4.4. Neurovascular Catheter
4.5. Specialty Center Catheters
4.5.1. Wound/Surgical Catheters
4.5.2. Oximetry Catheters
4.5.3. Thermodilution Catheters
4.5.4. IUI Catheters
4.5.5. Others
5. Catheters Market Size and Forecast, 2017-2025 by Region
5.1. Key Findings
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.3.1. UK
5.3.2. Germany
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.4. Asia-Pacific
5.4.1. China
5.4.2. Japan
5.4.3. India
5.4.4. Australia
5.5. Latin America
5.5.1. Brazil
5.5.2. Mexico
5.6. Middle East & Africa
6. Company Profiles
6.1. Johnson & Johnson
6.1.1. Overview
6.1.2. Financials
6.1.3. Product Benchmarking
6.1.4. Recent Developments
6.2. Abbott Laboratories
6.2.1. Overview
6.2.2. Financials
6.2.3. Product Benchmarking
6.2.4. Recent Developments
6.3. Becton, Dickson and Company
6.3.1. Overview
6.3.2. Financials
6.3.3. Product Benchmarking
6.3.4. Recent Developments
6.4. Braun Melsungen AG.
6.4.1. Overview
6.4.2. Financials
6.4.3. Product Benchmarking
6.4.4. Recent Developments
6.5. Medtronic plc.
6.5.1. Overview
6.5.2. Financials
6.5.3. Product Benchmarking
6.5.4. Recent Developments
6.6. Boston Scientific Corporation
6.6.1. Overview
6.6.2. Financials
6.6.3. Product Benchmarking
6.6.4. Recent Developments
6.7. Cook Group Incorporated
6.7.1. Overview
6.7.2. Financials
6.7.3. Product Benchmarking
6.7.4. Recent Developments
6.8. Teleflex Incorporated
6.8.1. Overview
6.8.2. Financials
6.8.3. Product Benchmarking
6.8.4. Recent Developments
6.9. Cardinal Health Inc.
6.9.1. Overview
6.9.2. Financials
6.9.3. Product Benchmarking
6.9.4. Recent Developments
6.10. Smith’s Medical
6.10.1. Overview
6.10.2. Financials
6.10.3. Product Benchmarking
6.10.4. Recent Developments
6.11. Arrow International Inc.
6.11.1. Overview
6.11.2. Financials
6.11.3. Product Benchmarking
6.11.4. Recent Developments
6.12. Edward Life Science Corporation
6.12.1. Overview
6.12.2. Financials
6.12.3. Product Benchmarking
6.12.4. Recent Developments
6.13. Coloplast
6.13.1. Overview
6.13.2. Financials
6.13.3. Product Benchmarking
6.13.4. Recent Developments